Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

VIVO Cannabis Inc. V.PDA


Primary Symbol: VVCIF

VIVO Cannabis Inc is a Canada-based company. It is involved in the production and sale of medical and recreational cannabis and the provision of cannabis-related medical information and services in Canada. The company's operating segment includes Cannabis, Patient Clinics, and Corporate. It generates maximum revenue from the Cannabis segment. The company has a presence across three geographical locations - Canada, Germany, and Australia.


OTCQB:VVCIF - Post by User

Bullboard Posts
Comment by kijijion Oct 06, 2018 8:42pm
214 Views
Post# 28758508

RE:Only thing you need to read about VIVO

RE:Only thing you need to read about VIVOTHIS IS GREAT STUFF

On October 04, 2018 Vivo Cannabis (VIVO.V) announced that it has entered into an agreement with Pharmascience which will make it easier for patients to use medical cannabis.
Pharmascience is a global pharmaceutical company based in Montreal that holds a Dealers License from Health Canada.
On behalf of Vivo, Pharmascience will employ “pharmaceutical quality standards” to create cannabis formulations that maximize therapeutic benefit to patients.
Vivo believes that health care professionals and patients will welcome the availability of precisely-controlled, high-quality, standardized dosage forms of cannabis.
“We are pleased to combine our strengths with those of Pharmascience for the benefit of our current and future medical patients,” stated Barry Fishman, CEO of Vivo.
Pharmascience is not small potatoes.  This 35-year-old private company has 1,500 employees and product distribution in over 60 countries.
 
Pharmascience manufactures and markets generic, over-the-counter, and behind-the-counter products, as well as FDA approved Canadian-made injectables – covering 300 product families in 20 different dosage forms.
In Canada alone, about 45 million prescriptions a year are filled with Pharmascience products.

Key Westleaf Deal Points:
-Multi-year supply agreement
-Vivo supplies cannabis to Westleaf.
-Vivo gains access to multiple retail locations
--Westleaf absorbs VIVO’s portfolio of adult-use brands
-FIRESIDE, Lumina and Canna Farms products delivered to Westleaf
 
Last week Vivo signed a deal with national cannabis distributor, Green Hedge Education & Distribution (GHED).
“The multi-year deal will facilitate the supply of Vivo Cannabis’ product to licensed retailers and wholesalers nationwide,” wrote Equity Guru’s Ethan Reyes.
Green Hedge is a “results-driven recreational cannabis distribution team” to representing Vivo’s key brands, including FIRESIDE, Lumina and Canna Farms.
 
On September 5, 2018 Vivo completed the acquisition of Canna Farms, British Columbia’s first licensed grower.
The acquisition cost Vivo $133 million, consisting of $22.5 million in cash and the issuance of 92.5 million common shares priced at $1.20 each.
 
Key Canna Farm Deal Points:
Enhanced Financial and Capital Markets Profile: strong cash position of $100 million.
Canna Farms’ positive operating cash flow – $9.4 million revenue EBITDA
Increased Capacity and Scale: Production capacity of 57,000 kilograms.
Multiple provincial supply agreements already secured.
International Leverage: Expedited expansion strategy into international markets, with a focus on Germany and Australia.

Bullboard Posts